1. Home
  2. MFA vs MDXG Comparison

MFA vs MDXG Comparison

Compare MFA & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MFA Financial Inc.

MFA

MFA Financial Inc.

HOLD

Current Price

$9.57

Market Cap

976.0M

Sector

Real Estate

ML Signal

HOLD

Logo MiMedx Group Inc

MDXG

MiMedx Group Inc

HOLD

Current Price

$6.35

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MFA
MDXG
Founded
1997
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
976.0M
1.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MFA
MDXG
Price
$9.57
$6.35
Analyst Decision
Buy
Buy
Analyst Count
7
2
Target Price
$10.96
$11.00
AVG Volume (30 Days)
1.3M
823.4K
Earning Date
02-18-2026
02-25-2026
Dividend Yield
15.29%
N/A
EPS Growth
N/A
N/A
EPS
0.86
0.27
Revenue
$279,011,000.00
$393,442,000.00
Revenue This Year
N/A
$19.13
Revenue Next Year
$3.18
$2.11
P/E Ratio
$10.96
$23.85
Revenue Growth
N/A
14.77
52 Week Low
$7.85
$5.79
52 Week High
$11.08
$9.36

Technical Indicators

Market Signals
Indicator
MFA
MDXG
Relative Strength Index (RSI) 51.62 34.88
Support Level $9.32 $6.25
Resistance Level $9.52 $6.50
Average True Range (ATR) 0.17 0.21
MACD -0.03 -0.07
Stochastic Oscillator 50.40 7.95

Price Performance

Historical Comparison
MFA
MDXG

About MFA MFA Financial Inc.

MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company's reportable segments include mortgage-related assets and Lima One.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: